Analyst Price Targets — GKOS
| Date | Analyst | Firm | Target | Price @ Post | Source | Headline |
|---|---|---|---|---|---|---|
| February 18, 2026 12:18 pm | David Saxon | Needham | $127.00 | $106.64 | TheFly | Glaukos price target raised to $127 from $125 at Needham |
| February 18, 2026 11:25 am | — | Wells Fargo | $135.00 | $106.64 | TheFly | Glaukos price target raised to $135 from $122 at Wells Fargo |
| January 28, 2026 5:18 pm | — | BTIG | $131.00 | $125.46 | TheFly | Glaukos price target raised to $131 from $123 at BTIG |
| January 22, 2026 12:32 pm | — | Stifel Nicolaus | $160.00 | $124.16 | TheFly | Glaukos price target raised to $160 from $115 at Stifel |
| January 14, 2026 12:59 pm | — | Piper Sandler | $165.00 | $100.62 | StreetInsider | Piper Sandler on Glaukos Corporation (GKOS): 'Strong Q4 Print Overshadowed Some By iDose Buy-Side Bogey' |
| January 9, 2026 10:49 am | — | Goldman Sachs | $138.00 | $114.15 | TheFly | Glaukos price target raised to $138 from $112 at Goldman Sachs |
| January 2, 2026 12:08 pm | — | Stephens | $145.00 | $112.91 | TheFly | Glaukos price target raised to $145 from $115 at Stephens |
| December 23, 2025 12:04 pm | — | UBS | $145.00 | $117.09 | TheFly | Glaukos price target raised to $145 from $140 at UBS |
| December 18, 2025 2:10 pm | — | Truist Financial | $145.00 | $115.85 | TheFly | Glaukos price target raised to $145 from $120 at Truist |
| December 17, 2025 12:02 pm | — | UBS | $165.00 | $113.76 | StreetInsider | Piper Sandler on Glaukos Corporation (GKOS): 'Our 2026 Top Idea' |
This site can’t be displayed in an embedded view
Some publishers block loading inside other sites for security reasons. You can open the article in a new tab instead.
Latest News for GKOS

Glaukos Corporation (NYSE: GKOS - Get Free Report) Director Aimee Weisner sold 15,000 shares of the company's stock in a transaction on Thursday, February 19th. The shares were sold at an average price of $117.38, for a total value of $1,760,700.00. Following the completion of the sale, the director owned 18,806 shares in the company, valued

GKOS posts 36% Q4 revenue jump, raises 2026 sales outlook to $600-$620M as iDose TR and Epioxa fuel growth despite wider loss.

Glaukos Corp (NYSE: GKOS) reported mixed results for the fourth quarter on Tuesday.

Glaukos Corporation (GKOS) Q4 2025 Earnings Call Transcript

While the top- and bottom-line numbers for Glaukos (GKOS) give a sense of how the business performed in the quarter ended December 2025, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
🧮 Earnings Move Analyzer
Insider Trading
Insider Trading
| Name | Role | Date | Type | Shares | Price | Form | Link |
|---|
Senate Trading
No Senate trades found for GKOS.
U.S. House Trading
No House trades found for GKOS.
Options Chain Settings
Changes apply instantly as you toggle. Tap Done when finished.
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.
